Joanne Doller Wojcik, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 21 | 2022 | 6865 | 0.740 |
Why?
|
| Psychotic Disorders | 6 | 2019 | 3044 | 0.290 |
Why?
|
| Lateral Ventricles | 2 | 2019 | 146 | 0.290 |
Why?
|
| Evoked Potentials, Auditory | 2 | 2019 | 504 | 0.280 |
Why?
|
| Diffusion Tensor Imaging | 7 | 2022 | 2305 | 0.250 |
Why?
|
| Schizophrenic Psychology | 6 | 2015 | 1671 | 0.240 |
Why?
|
| Corpus Callosum | 2 | 2019 | 736 | 0.220 |
Why?
|
| Myelin Sheath | 2 | 2019 | 652 | 0.150 |
Why?
|
| Anisotropy | 5 | 2022 | 1263 | 0.150 |
Why?
|
| Cognition Disorders | 4 | 2022 | 4041 | 0.150 |
Why?
|
| HIV Seropositivity | 1 | 2003 | 971 | 0.150 |
Why?
|
| Limbic System | 1 | 2019 | 424 | 0.140 |
Why?
|
| Acetylcysteine | 1 | 2018 | 271 | 0.140 |
Why?
|
| Prefrontal Cortex | 2 | 2018 | 2147 | 0.140 |
Why?
|
| Antipsychotic Agents | 8 | 2015 | 3057 | 0.140 |
Why?
|
| Clozapine | 3 | 2005 | 498 | 0.140 |
Why?
|
| Parahippocampal Gyrus | 1 | 2016 | 116 | 0.130 |
Why?
|
| Glutathione | 1 | 2018 | 590 | 0.130 |
Why?
|
| Caudate Nucleus | 1 | 2016 | 392 | 0.120 |
Why?
|
| Fornix, Brain | 1 | 2014 | 70 | 0.120 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2003 | 1443 | 0.120 |
Why?
|
| Community Health Nursing | 1 | 2013 | 24 | 0.110 |
Why?
|
| Suicide | 1 | 2003 | 1476 | 0.100 |
Why?
|
| Postnatal Care | 1 | 2013 | 236 | 0.100 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1991 | 166 | 0.090 |
Why?
|
| Depressive Disorder | 1 | 2003 | 3744 | 0.090 |
Why?
|
| Antioxidants | 1 | 2018 | 1658 | 0.090 |
Why?
|
| Brain | 6 | 2022 | 26345 | 0.090 |
Why?
|
| Young Adult | 15 | 2019 | 56392 | 0.090 |
Why?
|
| Mother-Child Relations | 1 | 2013 | 481 | 0.080 |
Why?
|
| Frontal Lobe | 1 | 2015 | 1395 | 0.080 |
Why?
|
| Risperidone | 2 | 2002 | 383 | 0.080 |
Why?
|
| Depression, Postpartum | 1 | 2013 | 340 | 0.080 |
Why?
|
| Dystonia | 1 | 1991 | 363 | 0.080 |
Why?
|
| Substance-Related Disorders | 2 | 2003 | 4254 | 0.080 |
Why?
|
| Age of Onset | 3 | 2015 | 3268 | 0.070 |
Why?
|
| Smoking | 1 | 2003 | 8984 | 0.070 |
Why?
|
| Cognition | 2 | 2022 | 6759 | 0.060 |
Why?
|
| Neuropsychological Tests | 5 | 2018 | 6976 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2016 | 6030 | 0.060 |
Why?
|
| Glucose Solution, Hypertonic | 1 | 2003 | 10 | 0.060 |
Why?
|
| Event-Related Potentials, P300 | 1 | 2005 | 149 | 0.060 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 5692 | 0.060 |
Why?
|
| Pirenzepine | 1 | 2002 | 115 | 0.050 |
Why?
|
| Organ Size | 2 | 2018 | 2241 | 0.050 |
Why?
|
| Risk | 3 | 2019 | 9677 | 0.050 |
Why?
|
| Adult | 21 | 2019 | 213889 | 0.050 |
Why?
|
| Male | 24 | 2021 | 349776 | 0.050 |
Why?
|
| Female | 24 | 2021 | 380020 | 0.050 |
Why?
|
| Adolescent | 10 | 2019 | 85729 | 0.050 |
Why?
|
| Prolactin | 1 | 2002 | 668 | 0.050 |
Why?
|
| Schizotypal Personality Disorder | 1 | 2001 | 288 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2018 | 2739 | 0.040 |
Why?
|
| Mental Recall | 3 | 2014 | 1206 | 0.040 |
Why?
|
| Menstrual Cycle | 1 | 2002 | 551 | 0.040 |
Why?
|
| Neuroleptic Malignant Syndrome | 2 | 1989 | 71 | 0.040 |
Why?
|
| Humans | 30 | 2022 | 743811 | 0.040 |
Why?
|
| Brain Mapping | 2 | 2016 | 6622 | 0.040 |
Why?
|
| Family | 1 | 2009 | 3144 | 0.040 |
Why?
|
| Behavioral Symptoms | 1 | 1999 | 175 | 0.040 |
Why?
|
| Neural Pathways | 2 | 2019 | 2971 | 0.040 |
Why?
|
| Nerve Net | 1 | 2009 | 2173 | 0.040 |
Why?
|
| Glutathione Peroxidase | 1 | 2018 | 255 | 0.040 |
Why?
|
| Demography | 1 | 2021 | 1653 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2019 | 1209 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 15526 | 0.030 |
Why?
|
| Acute Disease | 2 | 2016 | 7150 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2018 | 8939 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 1654 | 0.030 |
Why?
|
| Double-Blind Method | 4 | 2018 | 12020 | 0.030 |
Why?
|
| Delusions | 1 | 2015 | 300 | 0.030 |
Why?
|
| Hallucinations | 1 | 2015 | 358 | 0.030 |
Why?
|
| Memory | 3 | 2009 | 2173 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 2183 | 0.030 |
Why?
|
| Outpatients | 1 | 2019 | 1488 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 1524 | 0.020 |
Why?
|
| Nurse's Role | 1 | 2013 | 209 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2014 | 812 | 0.020 |
Why?
|
| Benztropine | 1 | 1989 | 17 | 0.020 |
Why?
|
| Tropanes | 1 | 1989 | 51 | 0.020 |
Why?
|
| Affect | 2 | 2015 | 1473 | 0.020 |
Why?
|
| Amantadine | 1 | 1989 | 55 | 0.020 |
Why?
|
| Memory, Short-Term | 1 | 2016 | 976 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2016 | 2369 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2015 | 1091 | 0.020 |
Why?
|
| Chlorpromazine | 2 | 2005 | 111 | 0.020 |
Why?
|
| Maprotiline | 1 | 1988 | 4 | 0.020 |
Why?
|
| Social Behavior | 1 | 2015 | 1126 | 0.020 |
Why?
|
| Comorbidity | 1 | 2003 | 10380 | 0.020 |
Why?
|
| Receptors, Cholinergic | 1 | 1989 | 238 | 0.020 |
Why?
|
| Focus Groups | 1 | 2013 | 1320 | 0.020 |
Why?
|
| Anthracenes | 1 | 1988 | 86 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2014 | 957 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 1991 | 929 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2016 | 6356 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 3758 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2013 | 1086 | 0.020 |
Why?
|
| Hospitals, Psychiatric | 1 | 1988 | 332 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39001 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 35409 | 0.020 |
Why?
|
| Middle Aged | 8 | 2019 | 213241 | 0.020 |
Why?
|
| Mood Disorders | 1 | 1991 | 1104 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2009 | 779 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2019 | 6061 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2013 | 2483 | 0.020 |
Why?
|
| Oxygen | 1 | 2016 | 4189 | 0.010 |
Why?
|
| Rest | 1 | 2009 | 901 | 0.010 |
Why?
|
| Saccharin | 1 | 2003 | 20 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 3320 | 0.010 |
Why?
|
| Attention | 3 | 2003 | 2393 | 0.010 |
Why?
|
| Self Report | 1 | 2014 | 3550 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13980 | 0.010 |
Why?
|
| Wechsler Scales | 1 | 2003 | 260 | 0.010 |
Why?
|
| Cocaine | 1 | 1988 | 1007 | 0.010 |
Why?
|
| Software | 1 | 2016 | 4440 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 2001 | 12954 | 0.010 |
Why?
|
| Hyperprolactinemia | 1 | 2002 | 129 | 0.010 |
Why?
|
| Menstruation Disturbances | 1 | 2002 | 148 | 0.010 |
Why?
|
| Verbal Learning | 1 | 2003 | 468 | 0.010 |
Why?
|
| Pilot Projects | 3 | 2001 | 8316 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13273 | 0.010 |
Why?
|
| Volition | 1 | 1999 | 63 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15067 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2018 | 77410 | 0.010 |
Why?
|
| Aging | 1 | 2018 | 8655 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 21733 | 0.010 |
Why?
|
| Progesterone | 1 | 2002 | 773 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2003 | 2029 | 0.010 |
Why?
|
| Sex Factors | 1 | 1991 | 10394 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 25032 | 0.010 |
Why?
|
| Benzodiazepines | 1 | 2002 | 1101 | 0.010 |
Why?
|
| Patient Readmission | 1 | 1989 | 3117 | 0.010 |
Why?
|
| Estradiol | 1 | 2002 | 2017 | 0.010 |
Why?
|
| Time Factors | 2 | 1999 | 40038 | 0.010 |
Why?
|
| Age Factors | 1 | 1991 | 18355 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2001 | 1546 | 0.010 |
Why?
|
| Family Health | 1 | 1999 | 1280 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 6487 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2013 | 25609 | 0.010 |
Why?
|
| Salivation | 1 | 1989 | 22 | 0.010 |
Why?
|
| Serial Learning | 1 | 1989 | 45 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1989 | 6593 | 0.010 |
Why?
|
| Personnel, Hospital | 1 | 1989 | 283 | 0.000 |
Why?
|
| Medical History Taking | 1 | 1989 | 782 | 0.000 |
Why?
|
| Random Allocation | 1 | 1989 | 2429 | 0.000 |
Why?
|
| Arousal | 1 | 1989 | 1160 | 0.000 |
Why?
|
| Clinical Trials as Topic | 2 | 1989 | 7908 | 0.000 |
Why?
|
| Health Education | 1 | 1989 | 1056 | 0.000 |
Why?
|
| Bipolar Disorder | 2 | 1989 | 5027 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1988 | 4931 | 0.000 |
Why?
|
| Aged | 1 | 1991 | 163178 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2002 | 53250 | 0.000 |
Why?
|
| Patient Compliance | 1 | 1988 | 2683 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1999 | 17439 | 0.000 |
Why?
|
| Length of Stay | 1 | 1988 | 6311 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1999 | 63042 | 0.000 |
Why?
|
| Risk Factors | 1 | 1988 | 72252 | 0.000 |
Why?
|